Viridian Therapeutics Inc (NASDAQ: VRDN) open the trading on N/A, with a bit cautious approach as it glided -1.44% to $21.27, before settling in for the price of $21.58 at the close. Taking a more long-term approach, VRDN posted a 52-week range of $9.90-$27.20.
The Healthcare sector firm’s twelve-monthly sales growth has been 31.28% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 31.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -9.88%. This publicly-traded company’s shares outstanding now amounts to $81.65 million, simultaneously with a float of $73.55 million. The organization now has a market capitalization sitting at $1.74 billion. At the time of writing, stock’s 50-day Moving Average stood at $18.59, while the 200-day Moving Average is $16.45.
Viridian Therapeutics Inc (VRDN) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Viridian Therapeutics Inc’s current insider ownership accounts for 9.93%, in contrast to 106.21% institutional ownership.
Viridian Therapeutics Inc (VRDN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.06 per share during the current fiscal year.
Viridian Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -9.88% and is forecasted to reach -4.04 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 19.51% through the next 5 years, which can be compared against the 31.28% growth it accomplished over the previous five years trading on the market.
Viridian Therapeutics Inc (NASDAQ: VRDN) Trading Performance Indicators
Let’s observe the current performance indicators for Viridian Therapeutics Inc (VRDN). It’s Quick Ratio in the last reported quarter now stands at 11.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5789.85.
In the same vein, VRDN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.27, a figure that is expected to reach -0.95 in the next quarter, and analysts are predicting that it will be -4.04 at the market close of one year from today.
Technical Analysis of Viridian Therapeutics Inc (VRDN)
[Viridian Therapeutics Inc, VRDN] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 90.91% While, its Average True Range was 67.73.
Raw Stochastic average of Viridian Therapeutics Inc (VRDN) in the period of the previous 100 days is set at 93.43%, which indicates a major rise in contrast to 83.85% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.92 that was higher than 0.86 volatility it exhibited in the past 100-days period.
